{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-336764","form_type":"8-K","ticker":"ORGO","cik":"0001661181","company_name":"Organogenesis Holdings Inc.","filed_at":"2021-11-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.548060+00:00","generated_at":"2026-06-28T06:08:48.618397+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Organogenesis appoints Prathyusha Duraibabu to board, regains Nasdaq audit committee compliance","bullets":["Prathyusha Duraibabu appointed independent director effective Nov 19, 2021; also joins audit committee.","Board now has eight members; appointment restores compliance with Nasdaq Listing Rule 5605(c)(2)(A).","Ms. Duraibabu received 11,340 RSUs vesting in equal annual installments over three years.","She is CFO of Sangamo Therapeutics; brings 24+ years in tech/healthcare and CPA qualification."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-336764","json":"https://secwatch.observer/filing/0001193125-21-336764.json","markdown":"https://secwatch.observer/filing/0001193125-21-336764.md","text":"https://secwatch.observer/filing/0001193125-21-336764.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661181/000119312521336764/0001193125-21-336764-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661181/000119312521336764/d210033d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T06:08:48.618397+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f57bcfcec4","claim":"Prathyusha Duraibabu was appointed as Independent Director at Organogenesis Holdings Inc..","evidence_excerpt":"Prathyusha Duraibabu had been appointed by the board of directors to serve as an independent director of the Company effective as of November 19, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661181/000119312521336764/0001193125-21-336764-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Independent Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}